Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Keytruda and epacadostat in metastatic urothelial carcinoma
NCT03374488Phase 3Completed
- Sponsor
- Incyte
- Start
- Dec 2017
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 18
01
Overview
A Phase 3 trial of epacadostat in urothelial carcinoma (UC), sponsored by Incyte. Started Dec 2017; status: completed.
02
Drugs
epacadostat
03
Conditions
urothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT03374488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03374488.